Urologists with experience in transurethral surgery will find transitioning to the Rezūm system simple and quick.

This one day training course equips new users to perform water vapour therapy with Rezūm through case discussions, review of evidence and simulation training.

 

Participation in training is a mandatory requirement before performing Rezūm treatments on your patients. Following completion of training you will receive a certificate that enables you to begin using Rezūm.

Powered by convective water vapor energy, the Rezūm System delivers targeted, controlled doses of the stored thermal energy in water vapor directly to the region of the prostate gland with the obstructive tissue causing the lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).

Each 9-second treatment uses 0.42ml of heated sterile water vapor which rapidly and uniformly disperses through the tissue interstices. The condensation of water vapor releases stored thermal energy. Cell membranes are denatured, thereby causing immediate cell death, the vasculature is closed, and there is denervation of the alpha-adrenergic nerves within the treatment zone providing you with an efficient, uniform, predictable treatment.

Over time, this ablated tissue is reabsorbed by the body’s natural healing response, reducing the volume of tissue allowing the urethra to open relieving LUTS.

The Rezūm procedure provides the following benefits to men suffering from BPH:

• Alternative to BPH medications¹
• Studies support Rezūm relieves symptoms safely and effectively²
• Noticeable symptom improvement within two weeks²
• Simple in-office/out-patient therapy²
• Does not require general anesthesia²
• Preserves erectile and urinary functions²
• Ability to return to regular activities within a few days^2*

 

 

*Dependent on individual clinical situation and healing response.

 

1. McVary KT, Rogers T, Roehrborn CG. Rezūm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology Gold Journal. 2019 Jan 23. [Epub ahead of print]

 

2. McVary KT, Gange SN, Gittelman MC, et al. Minimally invasive prostate convective water vapor energy (WAVE) ablation: A multicenter, randomized, controlled study for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2016; 195: 1529.

 

3. Data on file with Boston Scientific.

 

The Rezūm System is intended to relieve symptoms, obstructions, and reduce prostate tissue associated with BPH. It is indicated for men ≥ 50 years of age with a prostate volume 30cm3 ≤ 80cm3. The Rezūm System is also indicated for treatment of prostate with hyperplasia of the central zone and/or a median lobe.

English speaking urologists who are about to begin using Rezūm to treat their patients.

Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study.

 

• 10.30 Meet and Welcome from BSC and Faculty
• 11.00 Rezūm - principles, patient selection, planning treatment, technique tips and tricks, counselling patients and clinical evidence.
• 12.30 Lunch
• 1.15 Rezūm generator set-up
• 2.15 Rezūm simulated patient exercises
• 3.15 Patient-centric BPH care
• 4.00 close and departures